Da più di 20 anni il centro internazionale di ricerca Danone Research lavora a stretto contatto con le strutture cliniche più avanzate e le associazioni di professionisti più affermate, per sviluppare alimenti specifici di qualità altissima e per studiarne costantemente le proprietà.
Di seguito i riferimenti bibliografici di questi studi, aggregati per argomento:
| • |
Studi clinici pubblicati relativi alla sopravvivenza
del the Bifidobacterium lactis DN-173010 nel tratto gastrointestinale
|
Rochet
V., L. Rigottier-Gois, A. Ledaire, C. Andrieux, M. Sutren, S. Rabot, A.
Mogenet, J-L Bresson, S. Cools, C. Picard, N. Goupil-Feuillerat and J. Doré.
Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota
after administration in lyophilised form or in fermented product - a randomised
study in healthy adults. Journal of Molecular Microbiology and Biotechnology,
2008;14: 128-136.
He T., M. G. Priebe, Y. Zhong, C. Huang, H.J.M. Harmsen, G.C. Raangs, J.M.
Antoine, G.W. Welling and R.J. Vonk. Effect of yogurt and bifidobacteria
supplementation on the colonic microbiota in lactose-intolerant subjects.
Journal of Applied Microbiology, 2007; 104(2):595-604.
Collado M.C., Y. Moreno, J..M. Cobo, J.A. Mateos, M. Hernandez. Molecular
detection of Bifidobacterium animalis DN-173 010 in human feces during fermented
milk administration.
Food Research International, 2006; 39: 530-535.
Duez H., Pelletier C., Cools S., Aissi E., Cayuela C., Gavini F., Bouquelet
S., Neut C. and Mengaud J. A colony-immunoblotting method for quatitative
detection of a Bifidobacterium animalis probiotic strain in human faeces.
Journal of Applied Microbiology, 2000; 88:1019-27.
Pochart P., Marteau P., Bouhnik Y., Goderet I., Bourlioux P., Rambaud J.C.
Survival of Bifidobacteria ingested via fermented milk during their passage
through the human small intestine: an in vivo study using intestinal perfusion.
American Journal of Clinical Nutrition, 1992; 55:78-80.
Berrada N., Lemeland J.F., Laroche G., Thouvenot P., Piaia M. Bifidobacterium
from fermented milks: Survival during gastric transit. Journal of Dairy
Science, 1991; 74:409-413.
Pochart P., Marteau P., Bisetti N., Goderet I., Bourlioux P., Rambaud J.C.
Isolement des bifidobactéries dans les selles après ingestion prolongée
de lait au bifidus (LB).
No abstract available Médecine et Maladies Infectieuses 1990; 20: 75-78
(publication in French).
| • |
Studi sugli effetti del Bifidobacterium lactis DN-173010 sul transito gastrointestinale
|
Nishida
S., Ishikawa Y., Iino H. Effect of Bifidobacterium lactis DN-173 010
on the Intestinal Transit Time, the Condition of Defecation and Intestinal
Microflora: A randomized, Double-blind, Placebo-controlled, Cross-over Study
among Healthy Japanese Women. Pharmacometrics 2008;74 (5/6): 99-106.
Méance S., Cayuela C., Raimondi A., Turchet P., Lucas C. and Antoine J.M.
Recent advances in the use of functional foods: effects of the commercial
fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt
strains on gut transit time in the elderly. Microbial Ecology in Health
and Disease 2003; 15: 15-22.
Marteau P., Cuillerier E., Méance S., Gerhardt M.F., Myara A., Bouvier M.,
Bouley C., Tondu F., Bommelaer G., Grimaud J.C. Bifidobacterium animalis
strain DN-173 010 shortens the colonic transit time in healthy women : a
double blind, randomized, controlled study. Alimentary Pharmacology
and Therapeutics, 2002; 16: 587-593.
Méance S., Cayuela C., Turchet P., Raimondi A., Lucas C. and Antoine J.M.
A fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened
oro-fecal gut transit time in elderly. Microbial Ecology in Health and
Disease. 2001; 13: 217-222.
Bouvier M, Méance S, Bouley C, Berta JL and Grimaud JC. Effect of consumption
of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173
010 on colonic transit time in healthy humans. Bioscience Microflora.
2001; 20 (2): 43-48.
Yang Y., He M., Hu G., Wei J., Pages P., Yang X., Bourdu-Naturel S. Effect
of a fermented milk containing Bifidobacterium animalis DN-173 010 on Chinese
constipated women. World Journal of Gastroenterology, 2008; 14(40):
6237-6243.
| • |
Studi sugli effetti del Bifidobacterium lactis DN-173010 sul benessere gastrointestinale
|
Guyonnet
D., Woodcock A., Stefani B., Trevisan C. and Hall C.
Fermented milk containing Bifidobacterium lactis DN-173 010 improved
self-reported digestive comfort amongst a general population of adults.
A randomized, open-label, controlled, pilot study. Journal of Digestive
Diseases, 2009; 10: 61-70.
Agrawal A., Houghton L.A., Morris J., Reilly B.,D., Guyonnet D., Goupil-Feuillerat
N., Schlumberger A., Jakob S. & Whorwell P.J. Clinical trial: the effects
of a fermented milk product containing Bifidobacterium lactis DN-173-010
on abdominal distension and gastrointestinal transit in irritable bowel
syndrome with constipation. Alimentary Pharmacology and Therapeutics,
2009; 29(1): 104-114.
Guyonnet D, O. Chassany, P. Ducrotte, C. Picard, M. Mouret, C.H. Mercier
and C. Matuchansky.
Effect of a fermented milk containing Bifidobacterium animalis DN-173
010 on the health-related quality of life and symptoms in irritable bowel
symdrome adults in primary care. A multicentre, randomised, double-blind,
controlled trial.Alimentary Pharmacology and Therapeutics, 2007; 26
(3): 475-486.
Per maggiori approfondimenti su questi studi visita la pagina
http://www.studies.danone.com/index.html
